IP Library › Granted Patent US 10,130,604
Granted Patent B2
US 10,130,604 · App. 15/273,404 · Granted Nov 20, 2018

Composition and method for treating neurodegenerative disease

Inventors: Curt R. Freed (Denver, CO); Wenbo Zhou (Denver, CO)
Assignee: The Regents of the University of Colorado, a body corporate
A61K31/216A61K31/19A61K31/192A61K31/21H05K999/99
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,130,604
App. No.
15/273,404
Granted
Nov 20, 2018
Kind
B2
Abstract

The present invention provides a method and composition for treating a neurodegenerative disease. In particular, the present invention provides a method and composition to increase DJ-1 gene expression or DJ-1 protein activity to treat a neurodegenerative disease.

Claims (6)

1. A method for treating a neurodegenerative disease in a subject in need of such a treatment, the method comprising administering to the subject a composition comprising a therapeutically effective amount of a compound selected from the group consisting of phenylbutyric acid and butyric acid, or a salt thereof, wherein the neurodegenerative disease is selected from the group consisting of Parkinson's Disease and diffuse Lewy body disease.

2. The method of claim 1 , wherein the compound increases DJ-1 protein expression in the subject by at least 50%.

3. The method of claim 1 , wherein the compound increases DJ-1 protein expression in the subject by at least 100%.

4. The method of claim 1 , wherein the compound is phenylbutyric acid or, a salt thereof.

5. The method of claim 1 , wherein the compound is butyric acid or a salt thereof.

6. A method for treating a neurodegenerative disease in a subject in need of such a treatment, wherein the neurodegenerative disease is selected from the group consisting of Parkinson's Disease and diffuse Lewy body disease, the method comprising administering a therapeutically effective amount of a compound selected from the group consisting of phenylbutyric acid and butyric acid, or a salt thereof, wherein administration of the compound increases DJ-1 expression level by at least 150% in the subject, wherein increase in DJ-1 expression reduces neuron death in the subject.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 040135 FRAME: 0342. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 28, 2017
From: FREED, CURT R.; ZHOU, WENBO
To: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Reel/Frame 042366/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2016
From: FREED, CURT R.; ZHOU, WENBO
To: THE REGENTS OF THE UNIVERSITY OF COLORADO
Reel/Frame 040135/0342 →
Continuity (3)
Continuation 14388929
Provisional Application 61617055 · Mar 29, 2012
Related Publication 20170224646A1 · Aug 10, 2017
Cited By (1)
US 12,384,770